21.20.Z - Manufacture of medicines and other pharmaceutical products
21.1 - Manufacture of basic pharmaceutical substances
46.46 - Wholesale of pharmaceutical goods
47.73 - Dispensing chemist in specialised stores
47.74 - Retail sale of medical and orthopaedic goods in specialised stores
70.2 - Management consultancy activities
71.20.B - Other technical testing and analysis
72.11 - Research and experimental development on biotechnology
72.19 - Other research and experimental development on natural sciences and engineering
77.39 - Rental and leasing of other machinery, equipment and tangible goods not elsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Total operating revenue | 202 451,4 | |||
% | % | % | p.p. | |
Return on equity (ROE) | 79,1 | 48,8 | 40,4 | -8,4 |
Return on sales (ROS) | 12,7 | 11,1 | 5,7 | -5,4 |
Equity ratio | 49,8 | 68,7 | 52,9 | -15,8 |
Gross profit margin | 15,6 | 13,7 | 7 | -6,7 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 59 | 38 | 46 | 8 |
Current ratio | 1,9 | 2,5 | 1,7 | -0,8 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.